Ledger.Open graph →
SEC Form D · filed November 28, 2018

Gladius Pharmaceuticals Corp

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Atkin · Wilmington, DEExecAnne S. Walsh · Santa Monica, CAExecNathalie Chauret · Wilmington, DEDirectorLarry Sutton · Wilmington, DEDirectorJens Eckstein · Boston, MADirectorDaniel Hetu · Montreal, Quebec, CanadaDirectorJim Dauwalter · Golden Valley, MNExecNathalie Chauret · Wilmington, DEDirectorLarry Sutton · Wilmington, DEDirectorJens Eckstein · Montreal, Quebec, CanadaDirectorDaniel Hetu · Montreal, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗